One-liner#

Risk-stratify syncope to identify cardiac causes (arrhythmia, structural) requiring urgent evaluation, then efficiently manage the common benign causes (vasovagal, orthostatic) without over-testing low-risk patients. (Per 2017 ACC/AHA/HRS Syncope Guidelines and 2018 ESC Syncope Guidelines)

Quick nav#

Red flags / send to ED#

  • Syncope during exertion (not after)
  • Syncope while supine or seated
  • Syncope preceded by palpitations or chest pain
  • Family history of sudden cardiac death <50 years
  • Known structural heart disease (HCM, severe AS, arrhythmogenic cardiomyopathy, prior MI with reduced EF)
  • Abnormal ECG: long QT, short QT, Brugada pattern, WPW, bifascicular block, Q waves suggesting prior MI
  • New neurologic deficits (stroke mimic)
  • Significant injury from fall (head trauma, fracture)
  • Recurrent syncope without clear trigger
  • Syncope in patient with pacemaker/ICD (device malfunction)

Key history#

Characterize the event:

  • True syncope (complete LOC with spontaneous recovery) vs presyncope (near-faint) vs other (seizure, vertigo, hypoglycemia)
  • Duration of LOC (seconds = typical syncope; prolonged = seizure or cardiac arrest with resuscitation)
  • Prodrome: lightheadedness, warmth, nausea, tunnel vision, diaphoresis (vasovagal) vs none (cardiac)
  • Position: standing (orthostatic, vasovagal) vs sitting/supine (cardiac more likely)
  • Activity: exertional (cardiac) vs post-exertional (vasovagal) vs at rest

Triggers and context:

  • Prolonged standing, hot environment, dehydration, pain, blood draw, emotional stress (vasovagal)
  • Positional change: lying to standing (orthostatic)
  • Micturition, defecation, coughing, swallowing (situational)
  • Head turning, shaving, tight collar (carotid sinus hypersensitivity—elderly)
  • Medications: antihypertensives, diuretics, vasodilators, QT-prolonging drugs

Witness account (critical):

  • Movements during LOC: brief myoclonic jerks (common in syncope) vs sustained tonic-clonic activity (seizure)
  • Color: pallor (syncope) vs cyanosis (seizure, cardiac arrest)
  • Duration of confusion after: immediate recovery (syncope) vs prolonged postictal state (seizure)
  • Pulse during event if checked

Risk factors for cardiac syncope:

  • Age >60
  • Known heart disease: CAD, HF, valvular disease, cardiomyopathy
  • Family history: sudden death <50, HCM, long QT, Brugada, ARVC
  • Palpitations preceding syncope
  • Exertional syncope
  • Syncope while supine

Focused exam#

  • Vitals: orthostatic BP and HR (lying → standing at 1 and 3 minutes; positive if SBP drop ≥20 or DBP drop ≥10 with symptoms)
  • Cardiac: murmurs (AS, HCM), irregular rhythm, S3 (HF), JVD
  • Carotid: bruits (avoid carotid massage if bruit present)
  • Neuro: focal deficits (stroke), tongue laceration (seizure), postictal confusion
  • Skin: pallor, diaphoresis, injuries from fall
  • Rectal: if GI bleed suspected (melena, anemia)

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Vasovagal syncope“Felt hot,” “nauseated,” “vision went dark”Prodrome; trigger (standing, pain, blood); rapid recoveryNormal exam; may reproduce with prolonged standingReassurance; trigger avoidance; hydration
Orthostatic hypotension“Got up too fast,” “dizzy when standing”Positional; meds (diuretics, antihypertensives); dehydration; elderlyPositive orthostatic vitalsReview meds; hydration; compression stockings
Situational syncope“Passed out while urinating/coughing”Clear situational triggerNormal examAvoid trigger; sit during trigger activity
Medication-induced“Started new BP med”Temporal relationship to new/increased medicationOrthostatic hypotensionAdjust medication
Vasovagal (carotid sinus)“Turned my head,” “tight collar”Elderly; head turning triggerCarotid hypersensitivity (test with caution)Avoid triggers; cardiology if recurrent

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Arrhythmia (VT, bradycardia, SVT)“Heart racing then passed out,” no warningPalpitations before; known heart disease; abnormal ECGMay be normal between eventsECG; monitor; cardiology referral
Aortic stenosis“Passed out with exertion”Exertional; elderly; known murmurHarsh systolic murmur, diminished A2Echo; urgent cardiology
Hypertrophic cardiomyopathy“Passed out playing sports”Young; exertional; family hx sudden deathSystolic murmur that increases with ValsalvaEcho; urgent cardiology; activity restriction
Pulmonary embolism“Sudden,” “short of breath”VTE risk factors; dyspnea; pleuritic painTachycardia, hypoxiaED if suspected
Aortic dissection“Tearing pain,” “worst pain”Sudden severe pain; HTN; pulse deficitBP differential; new AR murmurED now
Seizure“Bit tongue,” “confused after,” “shaking”Prolonged LOC; witnessed tonic-clonic; postictalTongue laceration; postictal confusionNeuro workup
Hypoglycemia“Diabetic,” “missed meal”Diabetes on insulin/sulfonylurea; missed mealDiaphoresis; confusion; responds to glucoseCheck glucose; adjust diabetes regimen

Workup#

All patients:

  • ECG: look for arrhythmia, long/short QT, Brugada, WPW, heart block, prior MI (Q waves), LVH
  • Orthostatic vitals (lying → standing)
  • Basic labs: CBC (anemia), BMP (electrolytes, glucose), consider troponin if cardiac concern

Risk stratification tools:

Canadian Syncope Risk Score (CSRS) — validated for 30-day serious adverse events:

  • Predisposition to vasovagal: −1 point
  • Heart disease history or elevated BNP: +1 point
  • SBP <90 or >180 mmHg: +2 points
  • Elevated troponin: +2 points
  • Abnormal QRS axis: +1 point
  • QRS >130 ms: +1 point
  • QTc >480 ms: +2 points
  • ED diagnosis of cardiac syncope: +2 points
  • ED diagnosis of vasovagal syncope: −2 points
Score30-day riskDisposition
−3 to −10.4–1.2%Safe for outpatient
0–11.9–3.1%Consider outpatient with close follow-up
2–35.5–8.6%Consider observation/admission
≥412–25%Admission recommended

San Francisco Syncope Rule — older, less validated; CSRS preferred per 2017 ACC/AHA/HRS guidelines.

High-risk features (consider ED/admission):

  • Abnormal ECG
  • History of CHF or structural heart disease
  • Hematocrit <30%
  • Systolic BP <90
  • Shortness of breath
  • Age >60 with no clear vasovagal trigger

Low-risk features (outpatient workup appropriate):

  • Classic vasovagal prodrome and trigger
  • Young, healthy, normal ECG
  • Orthostatic hypotension with clear medication cause
  • Situational syncope with identifiable trigger

Extended workup by clinical scenario:

ScenarioWorkup
Low risk, classic vasovagalNo further workup; reassurance
Suspected orthostaticReview meds; volume status; consider autonomic testing if refractory
Suspected cardiac (abnormal ECG, structural heart disease, exertional)Echo ($300–800); Holter or event monitor ($100–300); cardiology referral
Recurrent unexplainedExtended monitoring (30-day event monitor, implantable loop recorder); tilt table ($500–1500) if vasovagal suspected but atypical

When to consider implantable loop recorder (ILR):

Per 2017 ACC/AHA/HRS guidelines, ILR is indicated (Class I) for:

  • Recurrent unexplained syncope after initial evaluation (ECG, orthostatics, echo if indicated) is non-diagnostic
  • Infrequent episodes (<monthly) unlikely to be captured by external monitors
  • High-risk features but no diagnosis after initial workup
  • Syncope causing significant injury requiring definitive diagnosis

ILR practical considerations:

  • Device cost: $5,000–10,000 (often covered by insurance with appropriate documentation)
  • Battery life: 3+ years of continuous monitoring
  • Implantation: minor outpatient procedure by cardiology/EP
  • Yield: diagnoses arrhythmia in 35–45% of unexplained syncope cases
  • Refer to cardiology/EP for implantation decision

Carotid sinus massage (CSM):

Indicated for: unexplained syncope in patients >40 years, especially with head-turning triggers

Technique (perform with continuous ECG and BP monitoring):

  • Patient supine with IV access available
  • Massage one carotid at a time for 5–10 seconds
  • Positive if reproduces symptoms with asystole >3 seconds or SBP drop >50 mmHg

Contraindications to CSM:

  • Carotid bruit
  • History of stroke/TIA within 3 months
  • Known carotid stenosis >50%
  • History of VT/VF
  • Recent MI

| Suspected seizure | EEG; MRI brain; neurology referral | | Suspected PE | Wells score; D-dimer or CT-PA |

When NOT to do extensive workup:

  • Single episode with classic vasovagal features, clear trigger, normal ECG, young healthy patient
  • Clear orthostatic hypotension from identifiable medication

Initial management#

  • Address immediate safety: driving restrictions until diagnosis clarified and treated
  • Treat reversible causes: stop/reduce offending medications; rehydrate
  • Risk stratify: low-risk patients can be managed outpatient; high-risk need ED/cardiology
  • Document: detailed history including witness account, ECG findings, orthostatic vitals

Management by diagnosis#

Vasovagal syncope#

Education:

  • Most common cause of syncope; not dangerous but can cause injury from falls
  • Recognize prodrome (lightheadedness, warmth, nausea) and respond immediately
  • Counterpressure maneuvers can abort episodes

Treatment:

Non-pharmacologic (first-line):

  • Recognize and avoid triggers when possible
  • At prodrome: lie down immediately, or if unable, cross legs and squeeze, squat, or grip hands tightly (counterpressure)
  • Increase fluid intake (2–3 L/day) and salt intake (if no HTN/HF)
  • Avoid prolonged standing; shift weight frequently
  • Compression stockings (waist-high more effective than knee-high)

Pharmacologic (if refractory and frequent):

DrugDoseContraindicationsMonitoringCostNotes
Midodrine2.5–10 mg TIDSupine HTN; urinary retention; severe CADSupine BP$$Alpha-agonist; avoid within 4h of bedtime; NNT ~4 for symptom reduction
Fludrocortisone0.1–0.2 mg dailyHF; HTN; hypokalemiaK, BP, edema, weight$Volume expansion; monitor for hypokalemia; limited RCT evidence
Beta-blockersVariableBradycardia; asthmaHR, BP$POST trial showed no benefit; may help subset with high catecholamine state

Per 2017 ACC/AHA/HRS guidelines, pharmacotherapy has limited evidence (Class IIb) and should be reserved for patients with frequent, recurrent vasovagal syncope despite non-pharmacologic measures.

Follow-up: 4–6 weeks if starting treatment; PRN if infrequent with good prodrome recognition. Driving restrictions per state law (typically no driving until symptom-free for specified period).


Orthostatic hypotension#

Education:

  • Blood pressure drops when standing, causing lightheadedness or fainting
  • Often medication-related or from dehydration
  • Gradual position changes and countermeasures help

Treatment:

Non-pharmacologic (first-line):

  • Rise slowly: sit at bedside before standing; wait 1–2 minutes
  • Increase fluid intake (2–3 L/day unless contraindicated)
  • Increase salt intake (if no HTN/HF)
  • Compression stockings (waist-high)
  • Elevate head of bed 10–20 degrees (reduces nocturnal diuresis)
  • Avoid large meals, alcohol, hot environments

Medication review:

  • Reduce/stop offending agents: diuretics, alpha-blockers, vasodilators, tricyclics, antipsychotics
  • Time antihypertensives to avoid peak effect during high-risk activities

Pharmacologic (if refractory):

DrugDoseContraindicationsMonitoringCostNotes
Midodrine2.5–10 mg TIDSupine HTN; urinary retentionSupine BP$$First-line pharmacotherapy; last dose by 6 PM
Fludrocortisone0.1–0.2 mg dailyHF; uncontrolled HTNK, BP, edema$Volume expansion; watch for supine HTN
Droxidopa100–600 mg TIDSevere CAD; concurrent pressor useSupine BP$$$$For neurogenic orthostatic hypotension
Pyridostigmine30–60 mg TIDBradycardia; asthma; GI obstructionHR; cholinergic symptoms$$May help without supine HTN

Follow-up: 2–4 weeks after medication changes; recheck orthostatic vitals. Consider autonomic specialist referral if refractory.

Managing supine hypertension (common with midodrine/fludrocortisone):

  • Elevate head of bed 10–20 degrees
  • Avoid supine position during day; last midodrine dose by 6 PM
  • If severe (SBP >180 supine): may need to reduce pressor dose or add bedtime short-acting antihypertensive (captopril 25 mg, losartan 25 mg, or hydralazine 25 mg)
  • Balance: some supine HTN is acceptable if orthostatic symptoms are controlled

When orthostatics are falsely negative:

  • Patient may be volume-repleted at time of testing (just drank fluids)
  • Symptoms may be postprandial (test after meals)
  • Autonomic dysfunction may require prolonged standing (10+ minutes) to manifest
  • Consider repeat testing or tilt table if high clinical suspicion

Cardiac syncope (arrhythmia, structural)#

Education:

  • Cardiac syncope is potentially life-threatening and requires thorough evaluation
  • Activity restrictions until cleared by cardiology
  • May require device therapy (pacemaker, ICD) or ablation

Treatment:

Immediate:

  • Cardiology referral (urgent if high-risk features)
  • Activity restriction: no driving, avoid heights, avoid swimming alone
  • Treat underlying condition per cardiology guidance

By etiology (cardiology-directed):

ConditionManagement
Bradycardia (sick sinus, AV block)Pacemaker
VT with structural heart diseaseICD; antiarrhythmics; ablation
SVT with syncopeAblation; AV nodal agents
Long QT syndromeBeta-blocker; avoid QT-prolonging drugs; ICD if high risk
Aortic stenosisValve replacement
HCMBeta-blocker; avoid dehydration; ICD if high risk

Follow-up: Per cardiology. PCP role is coordination, medication management, and ensuring compliance with activity restrictions.


Situational syncope#

Education:

  • Triggered by specific activities (urination, defecation, coughing, swallowing)
  • Benign but can cause injury; prevention is key
  • Same mechanism as vasovagal (vagal activation)

Treatment:

Non-pharmacologic:

  • Sit during triggering activities (especially micturition syncope—sit to urinate)
  • Avoid straining (treat constipation, suppress cough)
  • Stay hydrated
  • Recognize prodrome and use counterpressure maneuvers

Pharmacologic:

  • Rarely needed; same agents as vasovagal if refractory

Follow-up: PRN; reassurance is usually sufficient.

Follow-up#

  • Vasovagal, single episode, low risk: PRN; return if recurrent or change in pattern
  • Orthostatic hypotension: 2–4 weeks after intervention to recheck vitals
  • Cardiac syncope: per cardiology; PCP coordinates care
  • Unexplained recurrent: ensure monitoring completed; consider implantable loop recorder referral

Driving restrictions:

  • Varies by state and diagnosis
  • General guidance (verify local requirements):
    • Vasovagal with prodrome: typically can drive once trigger avoidance strategies in place; some states require symptom-free period (often 1–3 months)
    • Vasovagal without prodrome: longer restriction (3–6 months symptom-free)
    • Cardiac syncope: no driving until treated and cleared by cardiology (often 6 months for ICD, 1 week for pacemaker)
    • Unexplained syncope: no driving until diagnosis established
  • Commercial drivers: stricter requirements; often need cardiology clearance and longer symptom-free periods
  • Document counseling in chart

Elderly patients with multifactorial syncope:

  • Common scenario: orthostatic hypotension + polypharmacy + carotid sinus hypersensitivity + arrhythmia
  • Address ALL contributing factors, not just the most obvious one
  • Medication reconciliation is critical—often multiple culprits
  • Lower threshold for cardiology referral
  • Fall risk assessment and home safety evaluation

Patient instructions#

  • If you feel faint (lightheaded, warm, nauseated), lie down immediately or sit and put your head between your knees.
  • If you can’t lie down, cross your legs and squeeze your thighs together, or grip your hands and tense your arms—this can prevent fainting.
  • Rise slowly from lying or sitting; sit at the edge of the bed before standing.
  • Drink plenty of fluids (unless your doctor has restricted fluids) and don’t skip meals.
  • Avoid prolonged standing, hot environments, and alcohol.
  • Do not drive until your doctor says it’s safe.
  • Seek immediate care if you faint during exercise, have chest pain or palpitations before fainting, or injure yourself during a faint.

Smartphrase snippets#

  • Syncope, vasovagal: Classic prodrome (lightheadedness, warmth, nausea) with identifiable trigger (prolonged standing). Rapid recovery, no confusion. Normal ECG, negative orthostatics. Low risk. Discussed counterpressure maneuvers, hydration, trigger avoidance, and return precautions.

  • Syncope, orthostatic hypotension: Syncope/presyncope with position change. Orthostatic vitals positive (supine BP X, standing BP Y with symptoms). Likely medication-related [or dehydration]. Adjusted [medication]. Discussed slow position changes, hydration, and follow-up.

  • Syncope, high risk features: [Describe features]. ECG shows [findings]. Referred to cardiology urgently. Advised no driving until cleared. Discussed return precautions.

Coding/billing notes#

  • Document detailed history including prodrome, triggers, position, activity, witness account
  • Document orthostatic vitals with timing and symptoms
  • Document ECG interpretation
  • Document risk stratification reasoning
  • Document driving counseling
  • If not pursuing extensive workup, document rationale (e.g., “classic vasovagal with clear trigger, normal ECG, low-risk features”)

Key references#

  • 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (Circulation 2017)
  • 2018 ESC Guidelines for the Diagnosis and Management of Syncope (Eur Heart J 2018)
  • Canadian Syncope Risk Score validation (CMAJ 2016)
  • POST trial: beta-blockers in vasovagal syncope (Circulation 2006)